Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
27.22
-0.30 (-1.09%)
Nov 17, 2026, 3:00 PM CST

SHA:688076 Revenue

Jiangsu Sinopep-Allsino Biopharmaceutical had revenue of 607.83M CNY in the quarter ending September 30, 2026, with 26.92% growth. This brings the company's total for the last twelve months to 2.16B, up 13.86% year-over-year. In the year 2025, Jiangsu Sinopep-Allsino Biopharmaceutical had annual revenue of 1.94B with 19.57% growth. That makes Jiangsu Sinopep-Allsino Biopharmaceutical the 14,004th largest company in the world by revenue and 2,487th in China.

Revenue (ttm)
2.16B
Revenue Growth
+13.86%
P/S Ratio
3.99
Revenue / Employee
916.57K
Employees
2,360
Market Cap
8.62B

Revenue Chart

Revenue by Geography

  • Overseas 1.37B 70.3%
  • China 576.96M 29.7%
Fiscal year ended Dec 31, 2025 See the full SHA:688076 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.94B318.00M19.57%
Dec 31, 20241.62B591.25M57.21%
Dec 31, 20231.03B382.26M58.69%
Dec 31, 2022651.29M7.42M1.15%
Dec 31, 2021643.87M77.00M13.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.